Two-Year IVAN Results: Avastin, Lucentis Equally Effective

The two-year results of IVAN published July 19 in The Lancet show that Lucentis and Avastin are equally effective in treating neovascular or wet age-related macular degeneration.

http://www.revophth.com/content/d/review_news/i/2513/c/42255/